-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 10, the State Food and Drug Administration issued a notice (No.
59 of 2021) on 18 batches of drugs that did not meet the requirements
.
After inspection by 7 drug inspection institutions including Anhui Food and Drug Inspection and Research Institute, 18 batches of drugs, including cough peach powder, produced by 17 companies including Shaanxi Lijun Modern Chinese Medicine Co.
The relevant situation is now announced as follows:
1.
A batch of terazosin hydrochloride tablets produced by Wuhan Dongxin Pharmaceutical Technology Co.
The Yunnan Provincial Food and Drug Supervision and Inspection Institute showed that a batch of Chuanbei Qingfei Syrup produced by Wuhan Xinrui Pharmaceutical Co.
After inspection by Anhui Food and Drug Inspection and Research Institute, the 2 batches of Cough Peach Blossom Powder produced by Shaanxi Lijun Modern Chinese Medicine Co.
After inspection by Hubei Provincial Institute of Drug Supervision and Inspection, a batch of Atractylodes japonicus (fried atractylodes with bran) produced by Anhui Wukeng Chinese Medicine Decoction Pieces Co.
According to the inspection of Gansu Provincial Institute of Drug Inspection, the 2 batches of Bupleurum (Bupleurum vinegar) produced by Henan Huaxia Medicinal Materials Co.
After being inspected by Chongqing Food and Drug Inspection and Testing Research Institute, it is labeled as Liaoning Fushuntang Pharmaceutical Co.
2.
3.
